Related Announcements

RFA-DK-21-036 - Elucidating the Heterogeneity of Impaired Awareness of Hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed)

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice is to inform the applicant community of an increase in funds available for Funding Opportunity Announcement (FOA) RFA-DK-21-036, "Elucidating the Heterogeneity of Impaired Awareness of Hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed)". The amount committed for FY 2022 ($4.72 million) has not changed. However, the amounts allotted for the remaining years of the projects have increased.

Therefore, Section II., the Award Information, Award Budget section of the FOA has been updated to more accurately reflect the funds available.
 

Currently Reads:
 

Section II. Award Information
Award Budget

Application budgets need to reflect the actual needs of the proposed project. Application awards are limited to $500,000 Direct Costs in grant year 1; $1,000,000 Direct Costs in grant year 2; $1,000,000 Direct Costs in grant year 3, $1,000,000 Direct Costs in grant year 4 and $1,000,000 in Direct costs in grant year 5.
 

Modified to Read (changes shown in bold italics):

Section II. Award Information
Award Budget

Application budgets need to reflect the actual needs of the proposed project. Application awards are limited to $500,000 Direct Costs in grant year 1; $1,500,000 Direct Costs in grant year 2; $2,000,000 Direct Costs in grant year 3, $2,000,000 Direct Costs in grant year 4 and $1,500,000 in Direct costs in grant year 5.

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Karen Teff, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8803
Email: [email protected]